What is Prolensa?
Prolensa is a brand of the prescription eye drop bromfenac used for ophthalmic inflammation. It’s commonly associated with treatment around cataract surgery (anti-inflammatory eye therapy).
What is Prolensa (bromfenac) used for?
Prolensa is prescribed to treat inflammation in the eye following eye surgery, including cataract surgery. Bromfenac belongs to the class of medicines used to reduce inflammation in ocular tissues.
How is Prolensa typically used?
Prolensa is used as an ophthalmic solution (eye drop). Exact dosing schedules depend on the specific indication and the prescriber’s instructions.
Are there generic versions of Prolensa?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines. Checking Prolensa on DrugPatentWatch.com can help you see whether branded exclusivity is still active and whether generics may be available: DrugPatentWatch: Prolensa.
What should patients know about side effects?
As with other NSAID-type eye drops (bromfenac-containing products), patients typically ask about irritation or comfort issues and eye-related risks associated with inflammation and surgery. If you’re using Prolensa post-op, it’s important to follow the surgeon’s instructions closely and report worsening pain, vision changes, or unusual symptoms promptly.
Is Prolensa a steroid or an NSAID?
Prolensa contains bromfenac, which is an NSAID (not a steroid). That matters because NSAIDs and steroids can have different safety considerations and monitoring needs in the post-surgical setting.
Key patent/exclusivity questions to check
If you’re asking because of access or availability, the most practical next step is to verify:
- whether the Prolensa brand still has patent protection,
- when exclusivity may expire,
- and whether approved generic or alternative products are likely to enter.
DrugPatentWatch.com is a useful place to check these items for Prolensa: DrugPatentWatch: Prolensa.
Sources